Showing 301-310 of 10902 results for "".
- Valeant Terminates European Licensing Rights for Brodalumabhttps://practicaldermatology.com/news/valeant-terminates-european-licensing-rights-for-brodalumab/2458512/Valeant Pharmaceuticals International, Inc.'s affiliate and AstraZeneca have amended Valeant's license for brodalumab, an IL-17 receptor monoclonal antibody under regulatory review for patients with moderate-to-severe plaque psoriasis, to terminate Valeant's right to develop and comme
- Former Deputy Attorney General Appointed To Advise Valeant's Ad Hoc Committeehttps://practicaldermatology.com/news/former-deputy-attorney-general-appointed-to-advise-valeants-ad-hoc-committee/2458830/Valeant Pharmaceuticals International, Inc.’s ad hoc committee appointed by Valeant's board of directors has appointed former Deputy Attorney General of the United States Mark Filip of Kirkland & Ellis LLP to advise the committee in its review of allegations related to Valeant's
- Biosimilar Update: Fresenius Kabi’s Idacio Joins Growing List of Available Humira Biosimilarshttps://practicaldermatology.com/news/biosimilar-update-fresenius-kabis-idacio-joins-growing-list-of-available-humira-biosimilars/2461836/Fresenius Kabi’s citrate-free adalimumab biosimilar
- DefenAge's D2-Minute Reveal Masque Named NewBeauty's 2019 Best Brightening Maskhttps://practicaldermatology.com/news/defenages-d2-minute-reveal-masque-named-newbeautys-2019-best-brightening-mask/2459973/DefenAge’s D2-Minute Reveal Masque is the
- FDA Approves Ameluz PDT for Superficial Basal Cell Carcinomahttps://practicaldermatology.com/news/fda-approves-ameluz-pdt-for-superficial-basal-cell-carcinoma/2488430/The US Food and Drug Administration (FDA) has approved Biofrontera Inc.’s supplemental New Drug Application for Ameluz (aminolevulinic acid hydrochloride) topical gel, 10%, in combination with photodynamic therapy (PDT) using the BF-RhodoLED lamp series for the treatment of superficial basal cell
- AI-Assisted LC-OCT Detects Subclinical Basal Cell Carcinomahttps://practicaldermatology.com/news/ai-assisted-lc-oct-detects-subclinical-basal-cell-carcinoma/2488169/Artificial intelligence (AI)-assisted line-field confocal optical coherence tomography (LC-OCT) identified subclinical basal cell carcinoma (BCC) in clinically inconspicuous facial skin among patients at increased risk for BCC, according to results from a prospective cross-sectional feasibility s
- AI Beauty Tools May Favor Narrower Facial Aesthetic Standards: Supplementhttps://practicaldermatology.com/news/ai-beauty-tools-may-favor-narrower-facial-aesthetic-standards-supplement/2488121/Artificial intelligence (AI) is emerging as another influence on facial aesthetic standards, potentially affecting how patients perceive attractiveness and approach cosmetic procedures, according to brief review in The Journal of Craniofacial Surgery. The authors explored how AI s
- Dr. Darrell Rigel Highlights Urgent Skin Cancer Trends at Winter Clinical 2026https://practicaldermatology.com/news/dr-darrell-rigel-highlights-urgent-skin-cancer-trends-at-winter-clinical-2026/2485361/Skin cancer continues its upward trajectory, with new data showing that one in 19 Americans will be diagnosed with melanoma in their lifetime. This alarming statistic headlined a wide-ranging presentation by Darrell S. Rigel, MD, MS, at the 2026 Winter Clinical Dermatology Conference in Hawaii, w
- Dr. Darrell Rigel Highlights Advances in Skin Cancer Carehttps://practicaldermatology.com/news/dr-darrell-rigel-highlights-advances-in-skin-cancer-care/2484095/Darrell S. Rigel, MD, MS, provided a comprehensive update on the rapidly evolving landscape of skin cancer diagnosis, treatment, and prognostication at the 2025 Fall Clinical Dermatology Conference. From novel genetic assays to refinements in field therapy and systemic strategies, Dr. Rigel’s tal
- Upcoming Skin Cancer Champions Webinar Addresses Impact of AIhttps://practicaldermatology.com/news/Upcoming-Skin-Cancer-Champions-Webinar-Addresses-Impact-AI/2475627/Veronica Rotemberg, MD, PhD, will host a free webinar on the future of non-melanoma skin cancer care August 5 at 1:00 PM ET, Skin Cancer Champions announced. Dr. Rotemberg, Director of Dermatology Imaging Informatics for Memorial Sloan Kettering Cancer Center, will present “The Future of S